Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy

• Richard M. Gibson ,

  Contributed equally to this work with: Richard M. Gibson, Jan Weber

  Affiliation University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America

  ⨯
• Jan Weber ,

  Contributed equally to this work with: Richard M. Gibson, Jan Weber

  Affiliation Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic

  ⨯
• Dane Winner,

  Affiliation University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America

  ⨯
• Michael D. Miller,

  Affiliation Gilead Sciences, Inc., Foster City, California, United States of America

  ⨯
• Miguel E. Quiñones-Mateu

  * E-mail: meq@case.edu

  Affiliations University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America, Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯